KLRK1 and chronic graft versus host disease: Sustained NKG2D-mediated activation of alloreactive CD8+ T cells would be expected if only MICA-129Val variants are present that fail to efficiently downregulate NKG2D, and this could increase the risk of chronic GVHD but reduce the risk of relapse.